Skip to content

Zymeworks ZYME Book value per share

Book value per share at other companies

Pfizer logo
PfizerPFE
$15.72-0.6%
Amgen logo
AmgenAMGN
$16.89+47.2%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$0.44-60.0%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$7.43-22.1%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$3.10-9.9%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$6.26+6.2%

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.76B+125%
Enterprise value$1.53B+112%
P/S21.6×+13.2×

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Calculated from Zymeworks’s reported figures.

Based on the most recent quarter.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's book value per share?
Zymeworks (ZYME) reported book value per share of $2.19 in Q1 2026.
How has Zymeworks's book value per share changed year-over-year?
Zymeworks's book value per share decreased by 49.3% year-over-year, from $4.32 to $2.19.
What is the long-term trend for Zymeworks's book value per share?
Over 5 years (2020 to 2025), Zymeworks's book value per share has grown at a -15.2% compound annual growth rate (CAGR), from $8.14 to $3.56.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.